Endogenous lipid mediators in the resolution of airway inflammation

Haworth O., Levy B. D.

Source: Eur Respir J 2007; 30: 980-992
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Haworth O., Levy B. D.. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007; 30: 980-992

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Resolution of inflammation in airway diseases
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011

An update on anti-inflammatory endogenous mediators
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation.
Source: International Congress 2018 – Novel drug targets for asthma and COPD
Year: 2018

Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 25: 640-646
Year: 2005

Exploitation of anti-inflammatory mechanisms for the treatment of severe asthma
Source: Annual Congress 2005 - Mechanisms of resolution of inflammation
Year: 2005

New anti-inflammatory activities of Alpha-1-Antitrypsin and their role in COPD
Source: Annual Congress 2005 - Protease-antiprotease revisited
Year: 2005

The clinical importance of measuring airway inflammation
Source: Annual Congress 2005 - Are we ready for "inflammometry"? The role of eNO in asthma management
Year: 2005

Resolution of acute lung injury and inflammation: a translational mouse model
Source: Eur Respir J 2012; 39: 1162-1170
Year: 2012

Endogenous mediators of resolution
Source: Annual Congress 2006 - Resolution of airway and tissue inflammation “ emerging concepts
Year: 2006

Development of new treatments for complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006

ß2-adrenoceptor (ß2-AR) dysfunction in airway smooth muscle in severe asthma: possible role of inflammatory cytokines
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020

IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling
Source: International Congress 2019 – Advances in asthma pharmacology
Year: 2019

Rhinitis, nasal polyposis and asthma: pathological aspects
Source: ISSN=1025-448x, ISBN=1-904097-19-18, page=115
Year: 2001

Inflammatory mediators in nasal lavage, induced sputum and serum of employees with rheumatic and respiratory disorders
Source: Eur Respir J 2001; 18: 542-548
Year: 2001

Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Source: Eur Respir J 2008; 31: 396-406
Year: 2008

Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003

Are we ready to monitor inflammation and remodelling in asthma?
Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not?
Year: 2005

Bronchial inflammatory changes in wheezy infants
Source: Annual Congress 2007 - Bronchial inflammation in wheezing infants and pre-school children
Year: 2007

Role of neutrophils in airway inflammation in children with severe persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002